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Background
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• The Milwaukee Estuary AOC is at the confluence of 
Milwaukee, Menomonee, Kinnickinnic Rivers and 
Lake Michigan. 
• AOC receives discharges from wastewater 
treatment plants, industrial operations, combined 
sewer overflows, and agricultural and urban run-off.
• Aquatic biota likely exposed to multiple 
xenobiotics of varying chemical classes. 
• Presents a practical challenge for risk assessors and 
regulators. 
Study Objectives: 
▪ Identify chemicals detected in Milwaukee Estuary 
AOC.
▪ Prioritize contaminants to help focus risk assessment, 
regulatory, and research efforts. 
Study Sites
2017-18 Sites
• Kinnickinnic River at Lincoln (KKL)
• Menomonee River at 25th St (MET)
• Menomonee River at Freistadt Road 
(MEF)
• Milwaukee at Estabrook (MIE)
• Milwaukee at Mouth (MIM)
• Milwaukee River at Walnut St. (MIP)
• Menomonee near Church St. at 
Wauwatosa (MEC)
• Underwood Creek at Juneau Blvd (UCJ)
2018 (only) Sites
• Jones Island STP Plume (JIP)
• Cedar Creek at Green Bay Rd at 
Cedarburg (CCM)
• Milwaukee River at Cnty Trnk Hwy 
(MIN)
Control
▪ Great Lakes Ecotoxicology Division 
Laboratory (MED; Duluth, MN)
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Experimental Methods
▪ Caged fathead minnows deployed at study sites for a 96-h exposure 
period.
▪ Plasma (steroid hormones; E2, T)
▪ Liver (gene expression; CYP1A1, CYP3A, UGT1A1)
▪ Intestine (gene expression – 2017 only; CYP1A1, CYP3A, CYP2N13, CYP2AD6, 
UGT1A1)
▪ Autosampler co-located to collect 96-h composite samples.
▪ Chemistry (nutrients, wastewater indicators (69 analytes), pharmaceuticals 
(110 analytes)).





▪ 46/179 chemicals detected at ≥ 1 site(s)
▪ 77/179 chemicals detected at ≥ 1 site(s)
2018
83 unique compounds detected across study years; 




Milwaukee Estuary AOC Caged Fish Study
Chemistry: Chemical Detects (water, sediment)
In vivo data: Steroid Hormones (plasma); Gene Expression (liver, intestine).
In vitro data: Attagene, estrogenic activity
Weight-of-Evidence 









































𝛴𝑃𝑆𝑑𝑒𝑡𝑒𝑐𝑡 + σ𝑃𝑆𝑓𝑎𝑡𝑒 + σ𝑃𝑆𝑏𝑒𝑛𝑐ℎ𝑚𝑎𝑟𝑘 + σ𝑃𝑆𝑒𝑓𝑓𝑒𝑐𝑡
𝐶𝑃𝑆𝑚𝑎𝑥
𝑥 100
▪ Spatial Frequency: Detection across study sites. 
▪ Temporal Frequency: Detection across study years.
▪ Environmental Distribution: Detection across 







≥ 50% of sites. 10
20 ≤ x < 50% of sites. 5
< 20 % of sites. 0
Temporal 
Frequency
nyear = 2, nunique_sites > 0 10
nyear = 2, nunique_sites = 0 5




Sediment + Water 5
Water or Sediment 0
Detection Characteristics
Environmental Fate
▪ Characterized using QSAR estimates (EPISuite, 
OPERA, BMFpred) or experimental data. 
▪ Persistence (t1/2, d) and bioaccumulation (BCF, 
L/kg) evaluated using ECHA PBT/vPvB 
classifications.
▪ Biomagnification characterized as described by 







Persistence t1/2, freshwater < 40 d 0
40 ≤ t1/2, freshwater < 60 d 5
t1/2 ≥ 60 d 10
Bioaccumulation BCF < 2000 0
2000 ≤ BCF < 5000 5
BCF ≥ 5000 10
Biomagnification BMF < 1 0
BMF > 1 10
Water Quality Benchmarks
▪ Compared detect concentrations to Canadian & US water quality benchmarks:
▪ Water Quality Criteria (WQC): 
▪ CCME Water Quality Guidelines; USEPA Water 
Quality Criteria
▪ Screening Values (SV): 
▪ Ecotoxicity thresholds (USEPA), aquatic life benchmark










≥ 50% detects exceed benchmark. 10
0 < x < 50 % detects exceed 
benchmark.
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No benchmark exceedence. 0
No available benchmark. DL
Acute water quality criteria. 10
Acute screening value. 7.5
Chronic water quality criteria. 5
Chronic screening value. 2.5
No benchmark exceedence. 0
No available benchmark. DL
Acute WQC Acute SV Chronic WQC Chronic SV
ECOTOX Benchmarks
▪ Compared detect concentrations to in vivo effect 
concentrations from the ECOTOX Knowledgebase.
https://cfpub.epa.gov/ecotox/
▪ QSAR (TEST, ECOSAR) used to generate ecotoxicity 
estimates for data-limited compounds.  
▪ ECOTOX Benchmark Types:










≥ 50% detects exceeded. 5
0 < x < 50 % detects exceeded. 2.5
No benchmark exceedence. 0
Benchmark Type Unadjusted benchmark. 5
Uncertainty- adjusted benchmark. 2.5
No benchmark exceedence. 0
QSAR-generated benchmark. DL
ሻmi n( 𝐸𝑓𝑓𝑒𝑐𝑡 𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛
𝐴𝐹𝑒𝑛𝑑𝑝𝑜𝑖𝑛𝑡 𝑥 𝐴𝐹𝑙𝑒𝑛𝑔𝑡ℎ 𝑥 𝐴𝐹𝑟𝑖𝑐ℎ𝑛𝑒𝑠𝑠
ToxCast Benchmarks
▪ Compared detect concentrations to in vitro




▪ EAR threshold of 10-3 used as ToxCast 
benchmark cut-off for exceedence frequency. 
▪ Number of chemical-assay combinations 
exceeding ToxCast benchmarks evaluated to 









≥ 50% detect exceedence. 2.5
0 < x < 50 % detect exceedence. 1.25
No benchmark exceedence. 0
Assay Exceedence Exceedence in ≥ 5 assays. 2.5
Exceedence in 0 < x <5 assays. 1.25
Did not exceed benchmark. 0
No available ToxCast assays. DL
Effect Covariance
▪ Chemicals prioritized based on covariance 
with endocrine related and xenobiotic 
metabolism related effects.
▪ Random forest regression used to generate 
predictive models – ‘important’ chemical 
predictors identified for each effect.
▪ Weight-of-evidence covariance prioritization 
of chemicals across effect categories. 
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Net-positive covariance in ≥ 50% 
of effect subgroups.
2.5
Net-positive covariance in 1 < x 
< 50 % of effect subgroups.
1.25
Insignificant/negative 
covariance across effect 
subgroups.
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Milwaukee AOC Prioritization: Key Findings


































▪ Prioritized of 83 chemicals detected in the Milwaukee Estuary AOC 
based on detection characteristics, environmental fate & 
ecotoxicological potential.
▪ 6 High Priority Compounds highlighted for further evaluation.
▪ 14 Low Priority Compounds highlighted that likely pose low risks to the 
Milwaukee Estuary AOC watershed. 
▪ 9 Data-Limited Compounds that require further 
ecotoxicological/environmental fate investigation before they can be 
adequately prioritized. 
Developed an alternative prioritization framework that can be employed or 
adapted to transparently prioritize contaminants within freshwater 
watersheds. Maloney et al. 2021, in prep.
Questions, Comments?
Thank you for your attention!
Endocrine-Related Activity
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Elevated endocrine-related activity in 2017 serum samples (MEF, MIE, MIM, MIP); 
elevated endocrine-related activity at most study sites in 2018. 
* Indicates statistical significance compared to GLTED laboratory control (MED, blue). 


















▪ AhR elevated at all sites but MEC & UWM. 
▪ PXR_cis elevated at all sites but UWM.
▪ PXR_trans elevated at MEC, MET & UCJ. 
2017
▪ AhR elevated at all sites but UWM. 
▪ PXR elevated at all sites but UWM.
▪ PPARg elevated at MET.
▪ PTGER2 partially elevated at KKL. 
▪ ERa elevated at KKL and JIP.
▪ ERE elevated at MIM and JIP. 
2018






































































































metabolism related effects 
elevated at MIE, MIM, MEC. 
▪ Elevated intestinal metabolic 
enzyme activity at 7/8 sites 
in 2017.
▪ Elevated hepatic metabolic 


























▪ Elevated hepatic metabolic 
enzyme activity at 8/11 sites 
in 2018.
